PPD Receives Medidata Accelerator Award for Clinical Trial Innovation
WILMINGTON, N.C. (October 25, 2018) – Pharmaceutical Product Development, LLC (PPD) has been honored by Medidata (MDSO) with its Medidata Accelerator Award, recognizing PPD’s commitment to innovation for advancing and accelerating the drug development process.
“It is exciting for PPD and its employees to be recognized by Medidata for its commitment to innovation in accelerating the drug development process,” said Niklas Morton, senior vice president of site and patient access for PPD, who accepted the award on the company’s behalf. “Our collaboration with Medidata has given us the opportunity to explore additional data assets as we continually enhance our efforts to help clients advance their goal of delivering life-changing therapies.”
PPD uses Medidata’s data-driven solutions to support its protocol optimization process, as well as to help site feasibility and selection on behalf of its clients. PPD’s multi-pronged approach to protocol and trial optimization includes using Medidata Edge Design Optimizer to help address the complexity of trials and to make it easier for patients to participate.
“Congratulations to PPD and all of our Architects of Hope award winners,” said Janet Butler, senior vice president of global partnerships for Medidata. “We’re proud of our strong partnership with PPD and the innovation we’re empowering together to accelerate drug research.”
The award was presented at Medidata NEXT NYC, a two-day conference featuring a variety of thought-provoking sessions highlighting innovation within each phase of the clinical development cycle.
PPD is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our clients and partners include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 47 countries and approximately 20,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help clients and partners bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health.